316-330 of 825
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiersTelehealth in MS Care: Addressing the Potential for Improvement and Concerns
Marisa McGinley, DO
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
NeuroFrontiersAddressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiersToxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
NeuroFrontiersSchizophrenia Diagnosis: The Importance of a Collaborative Approach
Ashley Baker, MSN, PMHNP
Morris Goldman, MD
Dara Sanandaji
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiersExamining the Role of Toxic Tau Proteins in Alzheimer's Disease
Andrew Wilner, MD, FACP, FAAN
George Bloom, PhD
New Study Shows EBV-Specific T-Cells Contribute to MS Development
NeuroFrontiersNew Study Shows EBV-Specific T-Cells Contribute to MS Development
J. William Lindsey
- advertisement
A Successful and Safe Stem Cell Therapy for Progressive MS
NeuroFrontiersA Successful and Safe Stem Cell Therapy for Progressive MS
Charles Turck, PharmD, BCPS, BCCCP
Stefano Pluchino, MD, PhD
PBA Treatment May Reverse Signs of Alzheimer’s Disease
NeuroFrontiersPBA Treatment May Reverse Signs of Alzheimer’s Disease
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Jini Naidoo, PhD
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
NeuroFrontiersAlzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Andrew Wilner, MD, FACP, FAAN
Marc Haut, PhD
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
NeuroFrontiersFirst Episode Psychosis: Improving Patient Outcomes Through Early Intervention
Ashley Baker, MSN, PMHNP
Hannah Brown, MD
Investigating the Risk of Schizophrenia Among ADHD Patients with Psychiatric Comorbidities
NeuroFrontiersInvestigating the Risk of Schizophrenia Among ADHD Patients with Psychiatric Comorbidities
Detecting MS Biomarkers: An IgG Antibody Blood Test Offers 90% Accuracy
NeuroFrontiersDetecting MS Biomarkers: An IgG Antibody Blood Test Offers 90% Accuracy
- advertisement
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
NeuroFrontiersInvestigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
Andrew Wilner, MD, FACP, FAAN
William A. Kilgo, MD
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
NeuroFrontiersAdverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
Andrew Wilner, MD, FACP, FAAN
Carri Polick, PhD, RN
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
NeuroFrontiersMS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
Jennifer Caudle, DO, FACOFP
Mitzi Joi Williams, MD
